The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Fluorescent Immunoassay-Global Market Insights and Sales Trends 2025
Synopsis
Fluorescent immunoassay has the advantages of high specificity, high sensitivity and good practicability, so it is used to measure bioactive compounds with low content, such as proteins (enzymes, antibodies), hormones (thyroid hormones, phthalein hormones), drugs and microorganisms.
The global Fluorescent Immunoassay market size is expected to reach US$ 162.8 million by 2029, growing at a CAGR of 1.6% from 2023 to 2029. The market is mainly driven by the significant applications of Fluorescent Immunoassay in various end use industries. The expanding demands from the Infectious Diseases, Endocrinology and Oncology,, are propelling Fluorescent Immunoassay market. ELISA, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Rapid Test segment is estimated at % CAGR for the next seven-year period.
The market for fluorescent immunoassays is growing due to their sensitivity and versatility. Trends include the development of multiplex assays capable of detecting multiple analytes simultaneously.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Fluorescent Immunoassay, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Fluorescent Immunoassay market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Fluorescent Immunoassay market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Fluorescent Immunoassay sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Fluorescent Immunoassay covered in this report include F.Hoffmann-La Roche Ltd(Switzerland), Siemens AG(Germany), Abbott Laboratories(U.S.), Beckman Coulter(U.S.), Ortho-Clinical Diagnostics(U.S.) and bioMerieux SA(France), etc.
The global Fluorescent Immunoassay market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
F.Hoffmann-La Roche Ltd(Switzerland)
Siemens AG(Germany)
Abbott Laboratories(U.S.)
Beckman Coulter(U.S.)
Ortho-Clinical Diagnostics(U.S.)
bioMerieux SA(France)
Global Fluorescent Immunoassay market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Fluorescent Immunoassay market, Segment by Type:
ELISA
Rapid Test
Global Fluorescent Immunoassay market, by Application
Infectious Diseases
Endocrinology
Oncology
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Fluorescent Immunoassay companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Fluorescent immunoassay has the advantages of high specificity, high sensitivity and good practicability, so it is used to measure bioactive compounds with low content, such as proteins (enzymes, antibodies), hormones (thyroid hormones, phthalein hormones), drugs and microorganisms.
The global Fluorescent Immunoassay market size is expected to reach US$ 162.8 million by 2029, growing at a CAGR of 1.6% from 2023 to 2029. The market is mainly driven by the significant applications of Fluorescent Immunoassay in various end use industries. The expanding demands from the Infectious Diseases, Endocrinology and Oncology,, are propelling Fluorescent Immunoassay market. ELISA, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Rapid Test segment is estimated at % CAGR for the next seven-year period.
The market for fluorescent immunoassays is growing due to their sensitivity and versatility. Trends include the development of multiplex assays capable of detecting multiple analytes simultaneously.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Fluorescent Immunoassay, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Fluorescent Immunoassay market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Fluorescent Immunoassay market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Fluorescent Immunoassay sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Fluorescent Immunoassay covered in this report include F.Hoffmann-La Roche Ltd(Switzerland), Siemens AG(Germany), Abbott Laboratories(U.S.), Beckman Coulter(U.S.), Ortho-Clinical Diagnostics(U.S.) and bioMerieux SA(France), etc.
The global Fluorescent Immunoassay market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
F.Hoffmann-La Roche Ltd(Switzerland)
Siemens AG(Germany)
Abbott Laboratories(U.S.)
Beckman Coulter(U.S.)
Ortho-Clinical Diagnostics(U.S.)
bioMerieux SA(France)
Global Fluorescent Immunoassay market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Fluorescent Immunoassay market, Segment by Type:
ELISA
Rapid Test
Global Fluorescent Immunoassay market, by Application
Infectious Diseases
Endocrinology
Oncology
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Fluorescent Immunoassay companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Fluorescent Immunoassay
1.1 Fluorescent Immunoassay Market Overview
1.1.1 Fluorescent Immunoassay Product Scope
1.1.2 Fluorescent Immunoassay Market Status and Outlook
1.2 Global Fluorescent Immunoassay Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Fluorescent Immunoassay Market Size by Region (2018-2029)
1.4 Global Fluorescent Immunoassay Historic Market Size by Region (2018-2023)
1.5 Global Fluorescent Immunoassay Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Fluorescent Immunoassay Market Size (2018-2029)
1.6.1 North America Fluorescent Immunoassay Market Size (2018-2029)
1.6.2 Europe Fluorescent Immunoassay Market Size (2018-2029)
1.6.3 Asia-Pacific Fluorescent Immunoassay Market Size (2018-2029)
1.6.4 Latin America Fluorescent Immunoassay Market Size (2018-2029)
1.6.5 Middle East & Africa Fluorescent Immunoassay Market Size (2018-2029)
2 Fluorescent Immunoassay Market by Type
2.1 Introduction
2.1.1 ELISA
2.1.2 Rapid Test
2.2 Global Fluorescent Immunoassay Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Fluorescent Immunoassay Historic Market Size by Type (2018-2023)
2.2.2 Global Fluorescent Immunoassay Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Fluorescent Immunoassay Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Fluorescent Immunoassay Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Fluorescent Immunoassay Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Fluorescent Immunoassay Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Fluorescent Immunoassay Revenue Breakdown by Type (2018-2029)
3 Fluorescent Immunoassay Market Overview by Application
3.1 Introduction
3.1.1 Infectious Diseases
3.1.2 Endocrinology
3.1.3 Oncology
3.2 Global Fluorescent Immunoassay Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Fluorescent Immunoassay Historic Market Size by Application (2018-2023)
3.2.2 Global Fluorescent Immunoassay Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Fluorescent Immunoassay Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Fluorescent Immunoassay Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Fluorescent Immunoassay Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Fluorescent Immunoassay Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Fluorescent Immunoassay Revenue Breakdown by Application (2018-2029)
4 Fluorescent Immunoassay Competition Analysis by Players
4.1 Global Fluorescent Immunoassay Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Fluorescent Immunoassay as of 2022)
4.3 Date of Key Players Enter into Fluorescent Immunoassay Market
4.4 Global Top Players Fluorescent Immunoassay Headquarters and Area Served
4.5 Key Players Fluorescent Immunoassay Product Solution and Service
4.6 Competitive Status
4.6.1 Fluorescent Immunoassay Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 F.Hoffmann-La Roche Ltd(Switzerland)
5.1.1 F.Hoffmann-La Roche Ltd(Switzerland) Profile
5.1.2 F.Hoffmann-La Roche Ltd(Switzerland) Main Business
5.1.3 F.Hoffmann-La Roche Ltd(Switzerland) Fluorescent Immunoassay Products, Services and Solutions
5.1.4 F.Hoffmann-La Roche Ltd(Switzerland) Fluorescent Immunoassay Revenue (US$ Million) & (2018-2023)
5.1.5 F.Hoffmann-La Roche Ltd(Switzerland) Recent Developments
5.2 Siemens AG(Germany)
5.2.1 Siemens AG(Germany) Profile
5.2.2 Siemens AG(Germany) Main Business
5.2.3 Siemens AG(Germany) Fluorescent Immunoassay Products, Services and Solutions
5.2.4 Siemens AG(Germany) Fluorescent Immunoassay Revenue (US$ Million) & (2018-2023)
5.2.5 Siemens AG(Germany) Recent Developments
5.3 Abbott Laboratories(U.S.)
5.3.1 Abbott Laboratories(U.S.) Profile
5.3.2 Abbott Laboratories(U.S.) Main Business
5.3.3 Abbott Laboratories(U.S.) Fluorescent Immunoassay Products, Services and Solutions
5.3.4 Abbott Laboratories(U.S.) Fluorescent Immunoassay Revenue (US$ Million) & (2018-2023)
5.3.5 Beckman Coulter(U.S.) Recent Developments
5.4 Beckman Coulter(U.S.)
5.4.1 Beckman Coulter(U.S.) Profile
5.4.2 Beckman Coulter(U.S.) Main Business
5.4.3 Beckman Coulter(U.S.) Fluorescent Immunoassay Products, Services and Solutions
5.4.4 Beckman Coulter(U.S.) Fluorescent Immunoassay Revenue (US$ Million) & (2018-2023)
5.4.5 Beckman Coulter(U.S.) Recent Developments
5.5 Ortho-Clinical Diagnostics(U.S.)
5.5.1 Ortho-Clinical Diagnostics(U.S.) Profile
5.5.2 Ortho-Clinical Diagnostics(U.S.) Main Business
5.5.3 Ortho-Clinical Diagnostics(U.S.) Fluorescent Immunoassay Products, Services and Solutions
5.5.4 Ortho-Clinical Diagnostics(U.S.) Fluorescent Immunoassay Revenue (US$ Million) & (2018-2023)
5.5.5 Ortho-Clinical Diagnostics(U.S.) Recent Developments
5.6 bioMerieux SA(France)
5.6.1 bioMerieux SA(France) Profile
5.6.2 bioMerieux SA(France) Main Business
5.6.3 bioMerieux SA(France) Fluorescent Immunoassay Products, Services and Solutions
5.6.4 bioMerieux SA(France) Fluorescent Immunoassay Revenue (US$ Million) & (2018-2023)
5.6.5 bioMerieux SA(France) Recent Developments
6 North America
6.1 North America Fluorescent Immunoassay Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Fluorescent Immunoassay Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Fluorescent Immunoassay Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Fluorescent Immunoassay Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Fluorescent Immunoassay Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Fluorescent Immunoassay Market Dynamics
11.1 Fluorescent Immunoassay Industry Trends
11.2 Fluorescent Immunoassay Market Drivers
11.3 Fluorescent Immunoassay Market Challenges
11.4 Fluorescent Immunoassay Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
